Sunitinib Capsules
| Product/Composition | Sunitinib Capsules |
|---|---|
| Form | Capsule |
| Strength | 12.5mg, 25mg, 50mg |
| Therapeutic use | Anti Cancer |
| Package Insert/Leaflet | Available upon request |
| Brand Name | Sutib, Sutinat, Suninat |
What is Sunitinib Capsule?
Sunitinib Capsules are targeted anticancer medicines used in the treatment of various types of cancers, including kidney cancer (renal cell carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET). It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work by blocking specific proteins that promote cancer cell growth and blood vessel formation.
Sunitinib is widely prescribed for advanced or metastatic cancers, helping to slow disease progression and improve patient survival.
Description
Sunitinib Capsules are oral chemotherapy medications available in multiple strengths (12.5 mg, 25 mg, and 50 mg) to allow flexible dosing based on the patient’s condition and treatment plan. This medicine works by targeting multiple receptor pathways involved in tumor growth and angiogenesis (formation of new blood vessels).
It is commonly used as a long-term treatment option and is known for its effectiveness in controlling cancer progression.
Uses of Sunitinib Capsules
- Treatment of advanced renal cell carcinoma (kidney cancer)
- Treatment of gastrointestinal stromal tumors (GIST) after failure of other therapies
- Treatment of pancreatic neuroendocrine tumors (pNET)
- Used in metastatic or progressive cancer conditions
Indications
- Indicated for adult patients with specific advanced cancers
- Prescribed when cancer has spread or is not responding to standard treatment
- Dosage depends on body condition and type of cancer
- Must be taken under strict supervision of an oncologist
Benefits
- Targets cancer cells and inhibits tumor growth
- Prevents formation of new blood vessels supplying tumors
- Helps slow disease progression
- Available in multiple strengths for dose flexibility
- Improves progression-free survival in many patients
Drug Interactions
Sunitinib may interact with several medications, including:
- Ketoconazole, Itraconazole
- Rifampin, Rifabutin
- Clarithromycin, Erythromycin
- Dexamethasone
- Warfarin and other anticoagulants
Always inform your doctor about all medications, supplements, or herbal products before starting treatment.
How Sunitinib Works
- Inhibits tyrosine kinase receptors involved in tumor growth
- Blocks blood supply to tumors (anti-angiogenic effect)
- Slows down multiplication of cancer cells
- Helps control tumor progression and spread
Warnings & Precautions
- May cause high blood pressure—regular monitoring required
- Risk of liver toxicity—periodic liver function tests recommended
- Can cause fatigue, diarrhea, and skin discoloration
- Use cautiously in patients with heart conditions
- Not recommended during pregnancy or breastfeeding
General Instructions
- Take the capsule exactly as prescribed by your doctor
- Swallow whole with water; do not crush or chew
- Can be taken with or without food
- Follow the treatment cycle as directed (e.g., 4 weeks on, 2 weeks off)
- Do not skip doses or stop treatment without medical advice
Storage Information
- Store in a cool, dry place away from heat and moisture
- Keep in original packaging
- Keep out of reach of children and pets
- Do not use expired medication
Special Advice for Patients
- Attend regular medical check-ups and lab tests
- Monitor blood pressure during treatment
- Report unusual symptoms like bleeding, swelling, or severe fatigue
- Maintain a balanced diet and stay hydrated
Why Choose Onco India International?
At Onco India International, we are committed to delivering high-quality, affordable, and globally trusted oncology medications. Our Sunitinib Capsules are manufactured under strict quality standards to ensure safety, effectiveness, and consistent results in cancer care.
